Vaxart Stock (NASDAQ: VXRT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 120.000 / 1.943M |
Day Range | - - - |
52 Wk Range | 0.530 - 1.590 |
Market Cap | $121.129M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 25 |
Short Interest | 9.94% |
Days to Cover | 9.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vaxart (NASDAQ: VXRT) through any online brokerage.
Other companies in Vaxart’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB) and FibroGen (NASDAQ:FGEN).
The latest price target for Vaxart (NASDAQ: VXRT) was reported by B. Riley Securities on Wednesday, January 31, 2024. The analyst firm set a price target for 2.00 expecting VXRT to rise to within 12 months (a possible 187.07% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Vaxart (NASDAQ: VXRT) is $0.6967 last updated Today at April 26, 2024 at 7:42 AM EDT.
There are no upcoming dividends for Vaxart.
Vaxart’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Vaxart.
Vaxart is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.